Compare Quest Diagnostics Inc (DGX) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Indonesia Energy Corporation Limited — how do they compare? Quest Diagnostics Inc trades at $237.51 (market cap $26.24B), while Indonesia Energy Corporation Limited trades at $2.99 (market cap $45.08M). The key difference: Quest Diagnostics Inc is far larger — about 582.1× Indonesia Energy Corporation Limited's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals.
| DGX | INDO | |
|---|---|---|
Market Cap | $26.24B | $45.08M |
Sector | Health | Energy |
52-Week High | $238.50 | $6.74 |
52-Week Low | $173.49 | $2.49 |
Enterprise Value | $32.00B | $40.46M |
Dividend Yield | 1.45% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $237.99, up 0.15% on the day, near its 52-week high. The stock shows strong momentum with consecutive earnings beats in 2026, including Q2 EPS of $3.12 versus $2.82 expected. Revenue growth accelerated to $11.04 billion in 2025, with net income margin at 9.19%. Technical indicators signal a bullish trend, while analyst consensus is a $249.50 price target. Recent news highlights AI integration and raised 2026 outlook amid robust testing demand.
The outlook for DGX is positive, driven by earnings momentum, strategic partnerships, and healthcare demand. Investment opportunity lies in sustained growth and dividend yield, but risks include margin pressure from lower-margin deals and high debt levels. Valuation at a P/E of 25.21 requires continued execution to justify upside.
Indonesia Energy Corporation (INDO) trades at $2.93, up 0.34% with a bullish technical signal. The stock shows negative profitability metrics including -253.4% net income margin and -26.95% ROE, though recent drilling operations at the Kruh Block indicate operational progress. Analyst consensus is unanimously bullish with 3 buy ratings. Technical indicators show bullish moving averages and neutral oscillators with RSI at 60.28.
While current fundamentals show significant losses, the company's active drilling program and 100% analyst buy rating suggest potential upside if operational execution improves. Key risks include execution challenges in oil exploration and sustained negative cash flow. The stock presents speculative potential for investors comfortable with high-risk energy exploration plays.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
